190 related articles for article (PubMed ID: 25163486)
41. Extracolonic Cancer Risk After Total Colectomy for Inflammatory Bowel Disease: A Population-based Cohort Study.
Mark-Christensen A; Erichsen R; Veres K; Laurberg S; Sørensen HT
J Crohns Colitis; 2020 Jun; 14(5):630-635. PubMed ID: 31811282
[TBL] [Abstract][Full Text] [Related]
42. Incidence and Risk Factors of Mental Illnesses Among Patients with Systemic Autoimmune Rheumatic Diseases: An 18-year population-based study.
Chu WM; Chao WC; Chen DY; Ho WL; Chen HH
Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38579187
[TBL] [Abstract][Full Text] [Related]
43. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
[TBL] [Abstract][Full Text] [Related]
44. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
[TBL] [Abstract][Full Text] [Related]
45. Incidence of Tuberculosis in Inflammatory Rheumatic Diseases: Results from a Lithuanian Retrospective Cohort Study.
Miltinienė D; Deresevičienė G; Nakčerienė B; Davidavičienė VE; Danila E; Butrimienė I; Dadonienė J
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764422
[No Abstract] [Full Text] [Related]
46. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
Onishi A; Sugiyama D; Kumagai S; Morinobu A
Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
[TBL] [Abstract][Full Text] [Related]
47. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.
Chen YJ; Wu CY; Huang YL; Wang CB; Shen JL; Chang YT
Arthritis Res Ther; 2010; 12(2):R70. PubMed ID: 20398365
[TBL] [Abstract][Full Text] [Related]
48. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
49. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
[TBL] [Abstract][Full Text] [Related]
50. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; Luo SF; Yu KH; Chou IJ; Tseng WY; Chang HC; Fang YF; Chiou MJ; See LC
Scand J Rheumatol; 2012 Feb; 41(1):44-9. PubMed ID: 22150162
[TBL] [Abstract][Full Text] [Related]
51. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
[TBL] [Abstract][Full Text] [Related]
52. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
53. Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan.
Chan TM; Luo SF; Yu KH; See LC; Huang LH; Kuo CF
Scand J Rheumatol; 2021 Mar; 50(2):132-138. PubMed ID: 33464145
[No Abstract] [Full Text] [Related]
54. Cancer in patients with rheumatic diseases exposed to TNF antagonists.
Carmona L; Abasolo L; Descalzo MA; Pérez-Zafrilla B; Sellas A; de Abajo F; Gomez-Reino JJ; ;
Semin Arthritis Rheum; 2011 Aug; 41(1):71-80. PubMed ID: 21093020
[TBL] [Abstract][Full Text] [Related]
55. Sleep apnea and subsequent cancer incidence.
Sillah A; Watson NF; Schwartz SM; Gozal D; Phipps AI
Cancer Causes Control; 2018 Oct; 29(10):987-994. PubMed ID: 30120643
[TBL] [Abstract][Full Text] [Related]
56. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
57. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
58. Elevated cancer incidence in patients with dermatomyositis: a population based study.
Airio A; Pukkala E; Isomäki H
J Rheumatol; 1995 Jul; 22(7):1300-3. PubMed ID: 7562762
[TBL] [Abstract][Full Text] [Related]
59. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
[TBL] [Abstract][Full Text] [Related]
60. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
